For patients with GC, because survival was significantly correlated with LUM expression, univariate and multivariate analyses were conducted on 317 GC patients according to the Cox proportional hazard regression model to evaluate the impact of LUM expression and other clinicopathological factors on survival. This evidence concerns the gene LUM and gastric cancer.